- Newest technology and treatments. Eye doctors (ophthalmologists) at Mayo Clinic offer the latest diagnostic technology and most advanced treatment options for Fuchs' dystrophy.
- Experience and expertise. Mayo Clinic ophthalmologists have extensive experience in treating Fuchs' dystrophy, including seeing nearly 1,000 people with this condition each year. Mayo Clinic eye specialists provide comprehensive care for people who seek answers about conditions and diseases of their eyes, and they have specialized training in cornea diseases.
- Latest research. For more than 30 years, Mayo Clinic has been a leader in research on Fuchs' dystrophy and cornea transplants. You may be able to participate in clinical studies, helping to further the understanding of the disease for your future treatment or for treatment of your relatives.
Mayo Clinic: Answers you can trust
At Mayo Clinic, we assemble a team of specialists who take the time to listen and thoroughly understand your health issues and concerns. We tailor the care you receive to your personal health care needs. You can trust our specialists to collaborate and offer you the best possible outcomes, safety and service.
Mayo Clinic is a not-for-profit medical institution that reinvests all earnings into improving medical practice, research and education. We're constantly involved in innovation and medical research, finding solutions to improve your care and quality of life. Your doctor or someone on your medical team is likely involved in research related to your condition.
Our patients tell us that the quality of their interactions, our attention to detail and the efficiency of their visits mean health care — and trusted answers — like they've never experienced.
Why Choose Mayo Clinic
What Sets Mayo Clinic Apart
July 22, 2014
- Facts about the cornea and corneal disease. National Eye Institute. http://www.nei.nih.gov/health/cornealdisease. Accessed Feb. 7, 2014.
- What is Fuchs' dystrophy? American Academy of Ophthalmology. http://www.geteyesmart.org/eyesmart/diseases/fuchs-dystrophy.cfm. Accessed Feb. 7, 2014.
- Patel SV, et al. Anterior corneal aberrations after Descemet's stripping endothelial keratoplasty for Fuchs' endothelial dystrophy. Ophthalmology. 2012;119:1522.
- Gipson IK. Age-related changes and diseases of the ocular surface and cornea. Investigative ophthalmology and visual science. 2013;54:ORSF48.
- Hamill CE, et al. Fuchs endothelial cornea dystrophy: A review of the genetics behind disease development. Seminars in Ophthalmology. 2013;28:281.
- Riggin EA. Decision Support System. Mayo Clinic, Rochester, Minn. Feb. 10, 2014.
- Wieben ED, et al. A common trinucleotide repeat expansion within the transcription factor 4 (TCF4, E2-2) gene predicts Fuchs corneal dystrophy. PLoS One. 2012;7:e49083. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0049083. Accessed Feb. 13, 2014.
- What is a comprehensive dilated eye exam? National Eye Institute. http://www.nei.nih.gov/healthyeyes/eyeexam.asp. Accessed Feb. 24, 2014.
- The Wills Eye Manual: Office and Emergency Room Diagnosis and Treatment of Eye Disease Gerstenblith AT, et al., eds. Disease. 6th ed. Philadelphia, Pa.: Wolters Kluwer Health Lippincott Williams & Wilkins; 2012. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=booktext&D=books3&AN=01626623/6th_Edition/2&XPATH=/OVIDBOOK%5b1%5d/METADATA%5b1%5d/TBY%5b1%5d/EDITORS%5b1%5d. Accessed Feb. 24, 2014.
- Robertson DM (expert opinion). Mayo Clinic, Rochester, Minn. March 5, 2014.
- Patel SV. Graft survival and endothelial outcomes in the new era of endothelial keratoplasty. Experimental Eye Research. 2012; 95:40.
- Patel SV (expert opinion). Mayo Clinic, Rochester, Minn. May 20, 2014.
- Baratz KH, et al. E2-2 protein and Fuchs's corneal dystrophy. New England Journal of Medicine. 2010;363:1016.